Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 5/2007

01.05.2007

Prognostic Factors After Resection for Hepatocellular Carcinoma in Nonfibrotic or Moderately Fibrotic Liver. A 116-Case European Series

verfasst von: Thierry Bège, Y. Patrice Le Treut, Jean Hardwigsen, Pascal Ananian, Hubert Richa, Pierre Campan, Stéphane Garcia

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to identify factors influencing prognosis after resection for hepatocellular carcinoma in the noncirrhotic liver and to measure the impact of moderate fibrosis on presentation and prognosis. A series of 116 primary procedures were performed for hepatocellular carcinoma in the noncirrhotic liver. These cases accounted for 42% of hepatic resections performed for hepatocellular carcinoma during the study period (1987–2005). Seventy-seven cases (58%) occurred in patients with nonfibrotic livers (Metavir score F0). The mean age was 61 years. The sex ratio was 3.5, with a female predominance before 50 years. Hepatitis B virus (HBV) or hepatitis C virus infection was found in 30% of patients. Symptoms were present in 64% of cases. Elevated serum alpha fetoprotein levels were observed in 44% of cases. Procedures involved minor hepatectomy in 40 cases, major hepatectomy in 72 cases, and transplantation in 4 cases. Postoperative mortality was 6% and morbidity was 31%. Complete resection was achieved in 90% of cases. The tumor was isolated in 72% of cases. The mean tumor diameter was 10.6 cm. Vascular invasion was observed in 48% of cases. Hepatocellular carcinoma in the nonfibrotic liver was associated with younger age and female sex, but there was no difference with other hepatocellular carcinoma with regard to histological or prognostic features. With a median follow-up of 79 months, overall survival was 40% for a median of 41 months. Multivariate analysis identified incomplete resection, vascular invasion, and HBV infection as independent factors of poor prognosis. In case of recurrence, repeat resection was feasible in 30% of cases with 69% survival at 5 years. Although hepatocellular carcinoma in the noncirrhotic liver is generally diagnosed at an advanced stage, its resectability remains high. As a result, hepatocellular carcinoma in the noncirrhotic liver accounts for a large proportion of cases in surgical series and has a better prognosis than hepatocellular carcinoma in the cirrhotic liver. Vascular invasion, incomplete resection, and HBV infection are independent factors of poor prognosis.
Literatur
1.
Zurück zum Zitat Nzeako, U. C., Goodman, Z. D., & Ishak, K. G. (1996). Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. American Journal of Clinical Pathology, 105, 65–75.PubMed Nzeako, U. C., Goodman, Z. D., & Ishak, K. G. (1996). Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. American Journal of Clinical Pathology, 105, 65–75.PubMed
2.
Zurück zum Zitat Johnson, P. J., & Williams, R. (1987). Cirrhosis and the aetiology of hepatocellular carcinoma. Journal of Hepatology, 4, 140–147.PubMedCrossRef Johnson, P. J., & Williams, R. (1987). Cirrhosis and the aetiology of hepatocellular carcinoma. Journal of Hepatology, 4, 140–147.PubMedCrossRef
3.
Zurück zum Zitat Bedossa, P., & Poynard, T. (1996). An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, 289–293.PubMedCrossRef Bedossa, P., & Poynard, T. (1996). An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, 289–293.PubMedCrossRef
4.
Zurück zum Zitat Bruix, J., & Sherman, M. (2005). Management of hepatocellular carcinoma. Hepatology, 42, 1208–1236.PubMedCrossRef Bruix, J., & Sherman, M. (2005). Management of hepatocellular carcinoma. Hepatology, 42, 1208–1236.PubMedCrossRef
5.
Zurück zum Zitat Le Treut, Y. P., Pons, J., Hardwigsen, J., Castellani, P., Campan, P., Hanna, X., et al. (1999). Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients. Chirurgie, 124, 485–493.PubMedCrossRef Le Treut, Y. P., Pons, J., Hardwigsen, J., Castellani, P., Campan, P., Hanna, X., et al. (1999). Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients. Chirurgie, 124, 485–493.PubMedCrossRef
6.
Zurück zum Zitat Pol, B., Campan, P., Hardwigsen, J., Botti, G., Pons, J., & Le Treut Y. P. (1999). Morbidity of major hepatic resections: A 100-case prospective study. European Journal of Surgery, 165, 446–453.PubMedCrossRef Pol, B., Campan, P., Hardwigsen, J., Botti, G., Pons, J., & Le Treut Y. P. (1999). Morbidity of major hepatic resections: A 100-case prospective study. European Journal of Surgery, 165, 446–453.PubMedCrossRef
7.
Zurück zum Zitat Edmonson, H. A., & Steiner, P. E. (1954). Primary carcinoma of the liver: Study of 100 cases among 48900 necropsies. Cancer, 7, 462–504.CrossRef Edmonson, H. A., & Steiner, P. E. (1954). Primary carcinoma of the liver: Study of 100 cases among 48900 necropsies. Cancer, 7, 462–504.CrossRef
8.
Zurück zum Zitat Shimada, M., Rikimaru, T., Sugimachi, K., Hamatsu, T., Yamashita, Y., Aishima, S., et al. (2000). The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. Journal of the American College of Surgeons, 191, 531–537.PubMedCrossRef Shimada, M., Rikimaru, T., Sugimachi, K., Hamatsu, T., Yamashita, Y., Aishima, S., et al. (2000). The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. Journal of the American College of Surgeons, 191, 531–537.PubMedCrossRef
9.
Zurück zum Zitat Nagasue, N., Ono, T., Yamanoi, A., Kohno, H., El-Assal, O. N., Taniura, H., et al. (2001). Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. British Journal of Surgery, 88, 515–522.PubMedCrossRef Nagasue, N., Ono, T., Yamanoi, A., Kohno, H., El-Assal, O. N., Taniura, H., et al. (2001). Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. British Journal of Surgery, 88, 515–522.PubMedCrossRef
10.
Zurück zum Zitat Chen, M. F., Tsai, H. P., Jeng, L. B., Lee, W. C., Yeh, C. N., Yu, M. C., et al. (2003). Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: Univariate and multivariate analysis. World Journal of Surgery, 27, 443–447.PubMedCrossRef Chen, M. F., Tsai, H. P., Jeng, L. B., Lee, W. C., Yeh, C. N., Yu, M. C., et al. (2003). Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: Univariate and multivariate analysis. World Journal of Surgery, 27, 443–447.PubMedCrossRef
11.
Zurück zum Zitat Chang, C. H., Chau, G. Y., Lui, W. Y., Tsay, S. H., King, K. L., & Wu C. W. (2004). Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Archives of Surgery, 139, 320–325.PubMedCrossRef Chang, C. H., Chau, G. Y., Lui, W. Y., Tsay, S. H., King, K. L., & Wu C. W. (2004). Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Archives of Surgery, 139, 320–325.PubMedCrossRef
12.
Zurück zum Zitat Bismuth, H., Chiche, L., & Castaing, D. (1995). Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections. World Journal of Surgery, 19, 35–41.PubMedCrossRef Bismuth, H., Chiche, L., & Castaing, D. (1995). Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections. World Journal of Surgery, 19, 35–41.PubMedCrossRef
13.
Zurück zum Zitat Fong, Y., Sun, R. L., Jarnagin, W., & Blumgart, L. H. (1999). An analysis of 412 cases of hepatocellular carcinoma at a Western center. Annals of Surgery, 229, 790–799.PubMedCrossRef Fong, Y., Sun, R. L., Jarnagin, W., & Blumgart, L. H. (1999). An analysis of 412 cases of hepatocellular carcinoma at a Western center. Annals of Surgery, 229, 790–799.PubMedCrossRef
14.
Zurück zum Zitat Lang, H., Sotiropoulos, G. C., Domland, M., Fruhauf, N. R., Paul, A., Husing, J., et al. (2005). Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. British Journal of Surgery, 92, 198–202.PubMedCrossRef Lang, H., Sotiropoulos, G. C., Domland, M., Fruhauf, N. R., Paul, A., Husing, J., et al. (2005). Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. British Journal of Surgery, 92, 198–202.PubMedCrossRef
15.
Zurück zum Zitat Laurent, C., Blanc, J. F., Nobili, S., Sa Cunha, A., le Bail, B., Bioulac-Sage, P., et al. (2005). Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. Journal of the American College of Surgeons, 201, 656–662.PubMedCrossRef Laurent, C., Blanc, J. F., Nobili, S., Sa Cunha, A., le Bail, B., Bioulac-Sage, P., et al. (2005). Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. Journal of the American College of Surgeons, 201, 656–662.PubMedCrossRef
16.
Zurück zum Zitat Dupont-Bierre, E., Compagnon, P., Raoul, J. L., Fayet, G., de Lajarte-Thirouard, A. S., & Boudjema, K. (2005). Resection of hepatocellular carcinoma in noncirrhotic liver: Analysis of risk factors for survival. Journal of the American College of Surgeons, 201, 663–670.PubMedCrossRef Dupont-Bierre, E., Compagnon, P., Raoul, J. L., Fayet, G., de Lajarte-Thirouard, A. S., & Boudjema, K. (2005). Resection of hepatocellular carcinoma in noncirrhotic liver: Analysis of risk factors for survival. Journal of the American College of Surgeons, 201, 663–670.PubMedCrossRef
17.
Zurück zum Zitat Azoulay, D., Castaing, D., Krissat, J., Smail, A., Hargreaves, G. M., Lemoine, A., et al. (2000). Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Annals of Surgery, 232, 665–672.PubMedCrossRef Azoulay, D., Castaing, D., Krissat, J., Smail, A., Hargreaves, G. M., Lemoine, A., et al. (2000). Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Annals of Surgery, 232, 665–672.PubMedCrossRef
18.
Zurück zum Zitat Balzan, S., Belghiti, J., Farges, O., Ogata, S., Sauvanet, A., Delefosse, D., et al. (2005). The “50–50 criteria” on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Annals of Surgery, 242, 824–828, discussion 828–829.PubMedCrossRef Balzan, S., Belghiti, J., Farges, O., Ogata, S., Sauvanet, A., Delefosse, D., et al. (2005). The “50–50 criteria” on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Annals of Surgery, 242, 824–828, discussion 828–829.PubMedCrossRef
19.
Zurück zum Zitat Pawlik, T. M., Poon, R. T., Abdalla, E. K., Zorzi, D., Ikai, I., Curley, S. A., et al. (2005). Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Archives of Surgery, 140, 450–457.PubMedCrossRef Pawlik, T. M., Poon, R. T., Abdalla, E. K., Zorzi, D., Ikai, I., Curley, S. A., et al. (2005). Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Archives of Surgery, 140, 450–457.PubMedCrossRef
20.
Zurück zum Zitat Bilimoria, M. M., Lauwers, G. Y., Doherty, D. A., Nagorney, D. M., Belghiti, J., Do, K. A., et al. (2001). Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Archives of Surgery, 136, 528–535.PubMedCrossRef Bilimoria, M. M., Lauwers, G. Y., Doherty, D. A., Nagorney, D. M., Belghiti, J., Do, K. A., et al. (2001). Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Archives of Surgery, 136, 528–535.PubMedCrossRef
21.
Zurück zum Zitat Le Treut, Y. P., Hardwigsen, J., Ananian, P., Saisse, J., Gregoire, E., Richa, H., et al. (2006). Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case control series. Journal of Gastrointestinal Surgery, 10, 855–862.PubMedCrossRef Le Treut, Y. P., Hardwigsen, J., Ananian, P., Saisse, J., Gregoire, E., Richa, H., et al. (2006). Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case control series. Journal of Gastrointestinal Surgery, 10, 855–862.PubMedCrossRef
22.
Zurück zum Zitat Minagawa, M., Makuuchi, M., Takayama, T., & Ohtomo, K. (2001). Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Annals of Surgery, 233, 379–384.PubMedCrossRef Minagawa, M., Makuuchi, M., Takayama, T., & Ohtomo, K. (2001). Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Annals of Surgery, 233, 379–384.PubMedCrossRef
23.
Zurück zum Zitat Pol, S. (2005). Epidemiology and natural history of hepatitis B. Revue du Praticien, 55, 599–606.PubMed Pol, S. (2005). Epidemiology and natural history of hepatitis B. Revue du Praticien, 55, 599–606.PubMed
24.
Zurück zum Zitat Beasley, R., Hwang, L., Lin, C., & Chien, C. (1981). Hepatocellular carcinoma and hepatitis B virus. Lancet, 2, 1129–1133.PubMedCrossRef Beasley, R., Hwang, L., Lin, C., & Chien, C. (1981). Hepatocellular carcinoma and hepatitis B virus. Lancet, 2, 1129–1133.PubMedCrossRef
Metadaten
Titel
Prognostic Factors After Resection for Hepatocellular Carcinoma in Nonfibrotic or Moderately Fibrotic Liver. A 116-Case European Series
verfasst von
Thierry Bège
Y. Patrice Le Treut
Jean Hardwigsen
Pascal Ananian
Hubert Richa
Pierre Campan
Stéphane Garcia
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 5/2007
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-006-0023-9

Weitere Artikel der Ausgabe 5/2007

Journal of Gastrointestinal Surgery 5/2007 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.